B · Normal
[Johnson & Johnson expects full-year sales of US$101 billion to US$101.4 billion, market estimate of US$101.24 billion] On October 13, Johnson & Johnson’s third-quarter sales were US$25.40 billion, with an estimate of US$25.4 billion; adjusted earnings per share in the third quarter were US$2.59, with an estimate of US$2.52. Johnson & Johnson expects full-year sales of US$101 billion to US$101.4 billion, with an estimate of US$101.24 billion; it expects full-year adjusted earnings per share of US$11.05 to US$11.15.
U.S. stock trends 🕐 2026-10-13 18:22
#Johnson & Johnson #U.S. stock trends
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

On October 13th, JPMorgan Chase’s stock price erased its earlier decline, with t 10-13 19:13 On October 13, JPMorgan Chase estimated that its fiscal year net interest income 10-13 19:12 On October 13, Truist Securities raised Meta’s target price from $763 to $1,000. 10-13 19:10 On October 13th, Federal Reserve Goolsby said that the artificial intelligence b 10-13 19:07 October 13th, JPMorgan Chase expects adjusted expenses for the full year of 2026 10-13 19:06 On October 13, streaming media giant Netflix obtained the exclusive broadcast ri 10-13 19:04

Comments

0/500
Captcha (click to refresh)
No comments yet